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http://www.biomedcentral.com/1471-2350/15/105RESEARCH ARTICLE Open AccessExome sequencing identifies mutations in ABCD1
and DACH2 in two brothers with a distinct
phenotype
Yanliang Zhang1, Yanhui Liu2, Ya Li1, Yong Duan1, Keyun Zhang3, Junwang Wang3 and Yong Dai4*Abstract
Background: We report on two brothers with a distinct syndromic phenotype and explore the potential
pathogenic cause.
Methods: Cytogenetic tests and exome sequencing were performed on the two brothers and their parents.
Variants detected by exome sequencing were validated by Sanger sequencing.
Results: The main phenotype of the two brothers included congenital language disorder, growth retardation,
intellectual disability, difficulty in standing and walking, and urinary and fecal incontinence. To the best of our
knowledge, no similar phenotype has been reported previously. No abnormalities were detected by G-banding
chromosome analysis or array comparative genomic hybridization. However, exome sequencing revealed novel
mutations in the ATP-binding cassette, sub-family D member 1 (ABCD1) and Dachshund homolog 2 (DACH2) genes in
both brothers. The ABCD1 mutation was a missense mutation c.1126G > C in exon 3 leading to a p.E376Q substitution.
The DACH2 mutation was also a missense mutation c.1069A > T in exon 6, leading to a p.S357C substitution. The
mother was an asymptomatic heterozygous carrier. Plasma levels of very-long-chain fatty acids were increased in both
brothers, suggesting a diagnosis of adrenoleukodystrophy (ALD); however, their phenotype was not compatible
with any reported forms of ALD. DACH2 plays an important role in the regulation of brain and limb development,
suggesting that this mutation may be involved in the phenotype of the two brothers.
Conclusion: The distinct phenotype demonstrated by these two brothers might represent a new form of ALD or
a new syndrome. The combination of mutations in ABCD1 and DACH2 provides a plausible mechanism for this
phenotype.
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Adrenoleukodystrophy (ALD; OMIM#300100) is a ser-
ious progressive, genetic disorder that affects the adrenal
glands, the spinal cord and the white matter of the nervous
system. It is thought to be caused by genetic defects in the
ATP-binding cassette, sub-family D member 1 (ABCD1)
(OMIM*300371) gene [1,2]. ALD is characterized by varia-
tions in phenotypic expression; seven ALD forms have
been reported so far, including childhood cerebral, ado-
lescent cerebral, adult cerebral, adrenomyeloneuropathy* Correspondence: daiyong2222@gmail.com
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reproduction in any medium, provided the or(AMN), Addison-only, asymptomatic or presymptomatic,
and olivo-ponto-cerebellar ALD [3,4]. However, there is
no exact genotype-phenotype correlation between ABCD1
defects and clinical phenotype. Furthermore, the combin-
ation of defects in ABCD1 with defects in other genes,
such as the hemophilia A gene [5] or DXS1357E [6], can
complicate and worsen the clinical phenotype.
We present two brothers with a distinct phenotype in-
cluding congenital language disorder, growth retardation,
severe intellectual disability, inattention, dysphoria, drool-
ing, heterophony, difficulty in walking and standing with-
out aid, standing on tiptoe with aid, urinary incontinence,
and fecal incontinence. To the best of our knowledge, no
cases with a similar phenotype have been reportedLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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quencing in the two brothers and their parents to screen
for potential pathogenic causes.
Methods
Subjects
Two brothers and their parents, as well as 500 un-
affected individuals (250 males and 250 females) of
matched geographical ancestry, were enrolled in this
study. The study was approved by the Shenzhen People’s
Hospital Ethics Committee, which abides by the Helsinki
Declaration on ethical principles for medical research in-
volving human subjects. Written informed consent was
obtained from all the participants or their guardians.
DNA extraction
Genomic DNA was obtained from peripheral blood lym-
phocytes from all individuals, using standard procedures [7].
Cytogenetic analysis
G-banding chromosome analysis (~850 bands) was per-
formed on cultures of peripheral blood lymphocytes
from the two brothers and their parents, according to
standard techniques [7].
Array comparative genomic hybridization
Array comparative genomic hybridization (array-CGH)
was performed using Agilent Technologies’ Array CGH
Kits (Santa Clara, CA, USA). This platform is 60-mer
oligonucleotide-based microarray that allows genome-
wide survey and molecular profiling of genomic aberra-
tions with a resolution of ~20 kb (Kit 244A). DNAs were
labeled by random priming (Agilent Technologies) for
2 h using Cy5-dUTP for test DNAs and Cy3-dUTP for
reference DNAs. Labeled products were column-purified.
After probe denaturation and pre-annealing with 50 μg of
Cot-1 DNA, hybridization was performed at 65°C with ro-
tation for 40 h. After two washing steps, the arrays were
analyzed using an Agilent scanner and Feature Extraction
10.5.0.1 software. The data were analyzed using CGH An-
alytics 4.0 software (Agilent Technologies). The Aberra-
tion Detection Method 2 algorithm was used to identify
aberrant intervals.
Exon capture and sequencing, read mapping and single
nucleotide polymorphism detection
Targeted capture and massive parallel sequencing of ap-
proximately 201,904 coding exons from genomic DNA
from the two patients and their mother were performed
using the Agilent SureSelect Human All Exon kit, fol-
lowing the manufacturer’s protocols. Briefly, genomic
DNA was sheared by sonication and the DNA fragments
were then purified using a QIAquick PCR Purification
Kit (Qiagen, Hilden, Germany). The fragment ends wererepaired and adaptors were ligated to the fragments
(NEBNext DNA sample prep, New England Biolabs).
The adapter-ligated templates were purified using Agen-
court AMPure SPRI beads and fragments with an insert
size of about 250 bp were excised. Extracted DNA was
amplified by ligation-mediated polymerase chain reac-
tion, purified, and hybridized to the SureSelect Biotinyl-
ated RNA Library ‘baits’ (Agilent) for enrichment. Each
captured library was then loaded on a HiSeq 2000 plat-
form for sequencing. Raw image files were processed
using Illumina Pipeline (v1.6) for base-calling with de-
fault parameters. SOAPaligner (v2.01) was used to align
the sequencing reads to the NCBI human genome refer-
ence assembly (build 36.3). Reads that aligned to the de-
signed target region were collected for single nucleotide
polymorphism (SNP) identification and subsequent ana-
lysis. The consensus sequence and quality of each allele
was calculated by SOAPsnp.
Detection of insertions and deletions
Insertions and deletions (Indels) in the exome regions
were identified by de novo assembly of the sequencing
reads. The reads were assembled using SOAPdenovo
with the 31-mer option enabled and the assembled con-
sensus sequences were then aligned to the reference
genome by LASTZ. The alignment result was passed to
axtBest to separate orthologous from paralogous align-
ments. Finally, breakpoints in the alignment were identi-
fied and the genotypes of Indels were annotated.
Variant analysis
To distinguish between potentially pathogenic mutations
and other variants, we only focused on non-synonymous
(NS) variants, splice acceptor and donor site mutations
(SS), and short coding Indels, anticipating that synonym-
ous variants would less likely to be pathogenic. The vari-
ants were compared and filtered using public databases,
including dbSNP (v129), 1000 Genome Project (20100208
release), eight HapMap exomes, and YH genome. A novel
variant was defined as one that did not exist in these
datasets. Only recessive models of inheritance (auto-
somal recessive model and X-linked recessive model)
were considered because of the normal phenotypes of
the parents.
Mutation validation




Patient 1: A 10-year-old boy was the result of the third
pregnancy of a 33-year-old, gravida six, para three, Chin-
ese woman. The father was 34 years old. The parents
Figure 2 Only with the aid, the patient 1 was able to stand
on tiptoe.
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was uncomplicated and the mother denied any exposure
to alcohol, teratogenic agents, irradiation or infectious
diseases during the pregnancy. The boy was born at full-
term and delivered by spontaneous vaginal delivery. His
birthweight was 2,500 g (3rd–10th centile), length was
46 cm (<3rd centile), and head circumference was 30 cm
(<3rd centile). His growth continued to be retarded, and
his weight was 28.5 kg (<50th centile), length was
101 cm (<3rd centile), and head circumference was
46.5 cm (<3rd centile) at 8 years old. He was noted to
have global developmental delay, particularly affecting
expressive language. He had never spoken using phrases
or ‘word combinations’. His hearing and vision were
normal. He had severe intellectual disability (IQ < 25)
and response retardation. His cognition, attention and
memory were impaired. He was often restless, crying
and drooling, was interested in strangers or novel things,
and was frequently incontinent. He had dental dysplasia,
with aberrant, dust-colored teeth; the maxillary teeth 11
and 21 were reversed, the 21 and 22 dental crowns were
incompletely erupted, bilateral deciduous canines were
ablated, and the distal ends of both maxillary and man-
dibular permanent dental crowns were moderately or
mildly tilted (Figure 1). His motor skills were impaired:
his manual dexterity and finger tapping were poor, he
was able to pick up chopsticks or a spoon, but could not
pick up small items or thread a needle. He was never
able to walk or stand without aid, and with aid, was only
able to achieve a wobbling walk on tiptoe (Figure 2). He
was unable to raise or flex his lower limbs freely, and they
were ice-cold and insensitive to pain, heat and cold, lead-
ing to frequent frostbite and burning (Figure 3). Labora-
tory tests, including white blood cell and platelets counts,
bleeding time, sedimentation rate, serum electrolytes
and protein, blood glucose, immune electrophoresis, C-Figure 1 The poorly developed permanent teeth of the patient 1.reactive protein, C3 complement, autoantibody screen-
ing, and antistreptolysin titer revealed no pathologic
findings. The concentrations of cortisol and adrenocor-
ticotropic hormone (ACTH) were normal, though most
sex hormones were lower than the reference values
(Table 1). The plasma level of very-long-chain fatty
acids (VLCFA) was elevated, with a C24/C22 ratio of
1.342 (reference interval: 0.788–1.090), and C26/C22
ratio of 0.086 (reference interval: 0.018–0.038). Sonog-
raphy, X-ray examination, magnetic resonance imaging
(MRI) and computed tomography (CT) scan showed noFigure 3 The lower limbs of the patient 1 showing many
wounds caused by frostbite or burn unconsciously.
Table 1 The hormones detection results of two brothers
Tests Results Reference
intervalsPatient 1 Patient 2
Triiodothyronine (T3) 1.79 2.35 1.3 ~ 3.1 nmol/L
Thyroxine (T4) 112.9 121.6 66 ~ 181 nmol/L
Free triiodothyronine (FT3) 4.13 5.28 3.10 ~ 6.80 pmol/L
Free thyroxine (FT4) 16.34 16.18 12 ~ 22 pmol/L
Thyrotropic-stimulating
hormone (TSH)
3.30 3.70 0.27 ~ 4.20 uIU/ml
Luteinizing hormone (LH) 0.549 0.234 1.70 ~ 8.60 mIU/ml
Follicle-stimulating
hormone (FSH)
1.67 0.935 1.5 ~ 12.4 mIU/ml
Prolactin (PRL) 84.69 81.83 98 ~ 456 uIU/ml
Estradiol (E2) 24.05 18.35 49.2 ~ 218 pmol/L
Testosterone (T) 0.069 0.069 9.90 ~ 27.80 nmol/L
Progesterone (P) 0.095 0.095 0.70 ~ 4.30 nmol/L
Corticosteroid (CRO) 196.2 166.5 171 ~ 536 nmol/L
Adrenocorticotropic
hormone (ACTH)
9.2 7.1 2.2 ~ 16.6 pmol/L
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aborted three times and her first child died of liver can-
cer at the age of 6 years. There was no family history of
chromosomal anomaly or similar case, until the birth of
a younger brother (patient 2) (Figure 4).
Patient 2: The younger brother of patient 1 was born
as the sixth child, 6 years after patient 1, at 40 weeks of
gestation after an uncomplicated pregnancy and delivery.
His birthweight was 2500 g (3rd–10th centile), length
was 45 cm (<3rd centile), and head circumference was
31 cm (3rd–10th centile). He started learning to walk at
1 year old, but his lower limbs were weak. He failed to
thrive, and his weight was 9 kg (<3rd centile), length was
80.5 cm (<3rd centile), and head circumference was
42.5 cm (<3rd centile) at 2.5 years. He had severe intel-
lectual disability (IQ < 25) and response retardation. He
was inattentive and often drooling, restless and crying.Figure 4 The Pedigree of the family. The open square: normal male ind
with an arrow: male proband; the open square with a slash: deceased male
a closed circle in center: asymptomatic female carrier.The muscular tension in his lower limbs was high, and
his muscle strength was low. He was unable to stand,
walk or speak, and was only able to stand with assistance
at the age of 3 years (Figure 5). He was frequently incon-
tinent. Sonography, X-ray examination, MRI and CT
scan showed no obvious abnormalities. Auditory brain-
stem response examination revealed a high frequency
hearing threshold in both ears (left ear: 60 db, right ear:
105 db). The concentration of ACTH was normal, but
cortisol and sex hormones were low (Table 1). The
plasma level of VLCFA showed an increased C24/C22
ratio of 1.428 (reference interval: 0.788–1.090), and C26/
C22 ratio of 0.092 (reference interval: 0.018–0.038). No
obvious abnormalities were found by other laboratory
tests.
Genetic findings
The karyotypes of the two brothers and their parents
were normal according to G-banding chromosome ana-
lysis. No submicroscopic chromosome aberrations were
detected by array-CGH.
The exomes in the two brothers and their mother
were sequenced. A total of 35,495,497 bases in 244,069
exons from 21,326 genes were targeted for sequencing.
An average of 3.8 Gb of effective sequence was gener-
ated per individual as 90 bp paired-end reads; 2.9 Gb
(76.3%) passed the quality assessment and aligned to the
human reference sequence, and 63.3% of the total bases
mapped to the targeted bases with a mean coverage of
64.3-fold (Table 2). About 96% of targeted bases were
sufficiently covered to pass our threshold for variant
calling. After identification of variants, we focused on
NS, SS and Indels, which were more likely to be patho-
genic mutations than other variants. Each sibling had
one or more NS/SS/Indel variants in ~3,000 genes.
Using public databases (dbSNP129, 1000 Genomes Pro-
ject, eight HapMap exomes and YH genome) as filters,
we identified 51 and 33 novel mutated genes in the two
brothers, respectively. We compared these genes fromividual; the closed square: affected male individual; the closed square
individual; the small closed circle: abortion; the open large circle with
Figure 5 The patient 2 was only able to stand with assistance.
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http://www.biomedcentral.com/1471-2350/15/105the two brothers with their mother to exclude variants that
were not compatible with an autosomal recessive model or
X-linked recessive model. This reduced the number of can-
didate genes to 14 and eight, respectively. Three candidate
genes were shared by both brothers: one autosomal gene
GNAQ (OMIM*600998) and two X chromosomal genes
ABCD1 and DACH2 (OMIM*300608) (Table 3).
Sanger sequencing demonstrated that the GNAQ mu-
tations were false positives, but the mutations in DACH2
and ABCD1 were accurate. The ABCD1 mutation was a
missense mutation c.1126G > C in exon 3, leading to a p.
E376Q substitution (Figure 6), and the DACH2 mutation
was also a missense mutation c.1069A > Tc.1069A > T in
exon 6, leading to ap.S357C substitution (Figure 7). The
mother was an asymptomatic heterozygous carrier
(Table 4). Sanger sequencing of 500 unaffected individ-
uals of matched geographical ancestry failed to detect
the ABCD1 mutation, while the DACH2 mutation was
present in one female. BLAST analysis (http://blast.ncbi.
nlm.nih.gov/Blast.cgi) indicated that both the mutations,
c.1126G >C transition (E376Q) of ABCD1 and c.1069A >
T transition (p.S357C) of DACH2, occurred in highly con-
served positions (Figure 6, 7). To assess the likelihood thatTable 2 Summary of original exome sequencing data






Patient 1 3.93 3.04 77.35 2.50 63.6
Patient 2 3.52 2.67 75.85 2.22 63.0
mother 4.05 3.13 77.28 2.57 63.4the two variants had functional impacts on the respective
proteins, the biophysical consequences of these variants
were predicted using PolyPhen-2. The variant c.1126G > C
transition (E376Q) of ABCD1 was considered likely to be
functionally benign, while the variant c.1069A > T transi-
tion (p.S357C) of DACH2 was likely to be functionally
damaging.Discussion
We report on two brothers who presented with a dis-
tinct phenotype. The potential pathogenic cause was in-
vestigated using G-banding chromosome analysis and
high-resolution array-CGH in the two brothers and their
parents, but no abnormalities were detected. Exome se-
quencing was therefore performed on the brothers and
their mother, to detect genetic variations. The small
sample and uncertain pathogenesis of the disease meant
that both autosomal recessive and X-linked recessive
models were possible. The rarity of the disorder makes it
unlikely that causative variants would be present in the
general population, and we therefore compared our de-
tected variants with those in dbSNP129, 1000 Genomes
Project, eight HapMap exomes and YH genome to elim-
inate shared variants. Sequencing and comparison of the
coding region from the affected brothers and their un-
affected mother, and filtering out of the benign changes
using public databases, led to the identification of three
candidate genes: one autosomal gene GNAQ and two X
chromosomal genes ABCD1 and DACH2. Subsequent
Sanger sequencing showed that the mutations in GNAQ
were false positives.
The ABCD1 mutation was a novel missense mutation,
c.1126G > C transition (E376Q), in exon 3. Several lines
of evidence support a causative role for this mutation in
the brothers’ phenotype: 1) ABCD1 mutation is consist-
ent with an X-linked recessive model, which was one of
the two possible inherited models; 2) the ABCD1 muta-
tion is not present in the public databases, including
dbSNP129, 1000 Genomes Project, eight HapMap
exomes and YH genome, and was not found in 500 nor-
mal ethnicity-matched controls, excluding the possibility
of an amino acid substitution polymorphism; and 3)
comparative analyses of ABCD1 in other species show










1 37.81 37.47 99.10 66.01
7 37.81 37.41 99.00 58.70
6 37.81 37.35 99.00 68.22
Table 3 Identification of the candidate genes for two
brothers by exome sequencing
Filter Case 1 Case 2
NS/SS/I 2983 2981
Not in dbSNP129, 1000 Genome Project,
eight HapMap exomes, and YH genome
51 33
Comparing to the mother 14 8
Shared by two cases 3
Each cell indicates the number of genes with nonsynonymous (NS) variants,
splice acceptor and donor site mutations (SS) and coding indels (I). Rows show
the effect of excluding from consideration variants found in dbSNP129, 1000
Genome Project, the eight HapMap exomes, and the YH genome. Columns show
the effect of requiring that NS/SS/Indel variants be observed in each case.
Figure 6 Genomic structure of the exons encoding the open reading
ten exons that encode untranslated regions (UTR) (orange) and protein codin
exon 3 of ABCD1 indicated the same mutation was present in two brothers a
conserved position in ABCD1 shown by comparison to the corresponding seq
Cricetulus = Cricetulus griseus; Pan = Pan troglodytes; Canis = Canis lupus fam
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protein (ALD protein) that belongs to the ATP-binding
cassette–transporter superfamily [6]. The peroxisomal
ATP-binding cassette transporter is involved in the im-
port of VLCFA into the peroxisome. Defects in ABCD1
have been shown to be associated with impaired peroxi-
somal β-oxidation and accumulation of saturated VLCFA
in all tissues of the body, and are considered to be the
underlying cause of ALD [1,3].
ALD is a rare X-linked demyelinating disorder affect-
ing the nervous system, adrenal cortex and testis [1,2],
and is characterized by variation in phenotypic expres-
sion [6,8,9]. To date, several clinical forms have been re-
ported in male patients (Table 5) [3,4,10-12]. The
cerebral forms, including childhood cerebral, adolescent
cerebral and adult cerebral, are associated with an in-
flammatory reaction in the cerebral white matter andframe of ABCD1 and identified mutations. ABCD1 is composed of
g sequence (blue) (upper panel). Sanger sequence of codons 375–377 in
nd their mother (middle panel). E376Q missense mutation was at a highly
uence of six vertebrates (lower panel). Rattus = Rattus norvegicus;
iliaris; Bos = Bos Taurus.
Figure 7 Genomic structure of the exons encoding the open reading frame of DACH2 and identified mutations. DACH2 is composed of
twelve exons that encode untranslated regions (UTR) (orange) and protein coding sequence (blue) (upper panel). Sanger sequence of codons
356–358 in exon 6 of DACH2 indicated the same mutation was present in two brothers and their mother (middle panel). S357C missense mutation
was at a highly conserved position in DACH2 shown by comparison to the corresponding sequence of six vertebrates (lower panel). Rattus = Rattus
norvegicus; Cricetulus = Cricetulus griseus; Pan = Pan troglodytes; Canis = Canis lupus familiaris; Bos = Bos Taurus.
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leading to a vegetative state within 6 months to 2 years
after onset of symptoms, followed by death at variable
ages [13,14]. In contrast, AMN mainly involves the
spinal cord and peripheral nerves, the inflammatory re-
sponse is absent or mild, and its progression is slower.Table 4 The exome sequencing and sanger sequencing result
Gene Chromosome Position Reference Exome sequ
(NCBI36/hg18) Patient 1
GNAQ 9 79,726,915 G G/T
GNAQ 9 79,726,932 T T/A
DACH2 X 85,856,344 A T
ABCD1 X 152,654,804 G CAMN usually presents with initial symptoms in adult
men aged from 20 years to middle-age. Affected individ-
uals develop progressive stiffness and weakness in the
legs, sphincter control abnormalities, and sexual dys-
function, and may also have serious cognitive and behav-
ioral disturbances over the decades [12]. Addison-onlys of the 3 candidate genes
encing Sanger sequencing
Patient 2 Mother Patient 1 Patient 2 Mother Father
G/T G G G G G
T/A T/A T T T T
T A/T T T A/T A
C C/G C C C/G G
Table 5 Phenotypic comparison between reported male ALD forms and two brothers
Forms Description Two brothers
Childhood cerebral Onset at 3–10 years of age with a peak at seven years.
This form virtually never occurs before three years of
age. Affected boys present with progressive behavioural
and cognitive neurological deficits, such as inattention,
hyperactivity, deterioration in handwriting skills,
diminishing school performance; difficulty in
understanding speech, spatial orientation; clumsiness;
visual disturbances; and aggressive behavior. Brain MRI
examination can be strikingly abnormal even when
symptoms are relatively mild. Most individuals have
impaired adrenocortical function at the time that
neurological disturbances are first noted. Total disability
often within 3 years.
Onset before 2 years of age. Presentation is not
progressive, including congenital language disorder,
intellectual disability, growth retardation, response
retardation, dysphoria, drooling; difficulty in walking and
standing; urinary incontinence and fecal incontinence;
movement and sensory dysfunctions of lower limbs;
normal brain MRI, normal adrenocortical function.
Adrenomyeloneuropathy (AMN) Onset at 28 ± 9 years, progressive stiffness and
weakness of legs, abnormalities of sphincter control,
sexual dysfunction, distal axonopathy, inflammation
mild or absent, mainly spinal cord involvement, cerebral
involvement later in 45% of cases.
Adolescent cerebral Like childhood cerebral, but onset at 10–21 years of
age. Somewhat slower progression.
Adult cerebral Dementia, behavioral disturbances. Rapid inflammatory
cerebral progression resembling the childhood form,
without preceding AMN, onset after 21 years of age.
Addison-only Primary adrenocortical insufficiency without neurological
abnormalities, including unexplained vomiting, weakness,
coma, onset before 7.5 years of age.
Asymptomatic or presymptomatic ALD gene abnormality without neurological or endocrine
abnormalities, further studies can reveal subclinical
adrenal insufficiency or mild AMN phenotype. This form is
common in boys under 4 years of age.
Olivo-ponto-cerebellar Cerebral and brain stem involvement, onset between
adolescence to adulthood.
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between 2 years of age and adulthood; the signs include
unexplained vomiting, weakness or coma. Individuals with
asymptomatic ALD usually have a biochemical abnormal-
ity, but no manifestation of adrenal or neurologic disease.
The cerebellum and brain stem are usually involved in in-
dividuals with olivo-ponto-cerebellar ALD, who present
with signs between adolescence and adulthood.
The unique phenotype of the two brothers initially
suggested a novel syndrome, rather than ALD. However,
a missense mutation in ABCD1 was unexpectedly identi-
fied in both brothers and their mother by exome se-
quencing. Although PolyPhen-2 predicted that the
biophysical consequences of the variant c.1126G > C
(E376Q) of ABCD1 were likely to be functionally benign,
other variants in the same exon, such as c.1114A > T (p.
K372*) and c.1137C > G (p.S379R), have been reported
to lead to ALD [15]. Further laboratory tests showed ele-
vated plasma VLCFA levels in the brothers, and no mu-
tations were detected in genes associated with other
peroxisomal diseases, such as Zellweger syndrome, acyl-
CoA oxidase deficiency, D-bi-functional protein defi-
ciency, and b-ketothiolase deficiency. The brothers should
be therefore diagnosed with ALD.Nevertheless, the phenotype exhibited by the two
brothers was not consistent with any reported ALD
forms. Their ages at onset would suggest childhood cere-
bral ALD (CCALD), but their conditions were not pro-
gressive, their brain MRI results were normal, and they
had severe congenital language and motor disorders and
intellectual disability. In contrast, cognitive and motor
development are normal in CCALD prior to the onset of
demyelinating lesions visible at brain MRI, suggesting
that the brothers’ phenotype differed from CCALD. In
addition, both brothers had urinary and fecal incontin-
ence, their ages at onset were younger than 2 years old,
they had severe congenital intellectual disabilities, and
were unable to walk and speak, indicating a phenotype
incompatible with AMN and other known forms of
ALD. The distinct phenotype displayed by the two
brothers suggests that other pathogenetic factors, in
addition to ABCD1 mutation, may have been responsible
for their condition.
DACH2 is a homolog of dachshund. The dachshund/
Dach gene family encodes transcriptional cofactors that
are conserved between insects and vertebrate. Drosoph-
ila dachshund is a critical regulator of eye, brain, and
limb formation, and null mutations in dachshund result
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ment [16-19]. The vertebrate homologs Dach1 and
Dach2 also play an important role in the development
of the retina, brain and limbs [20]. DACH2 encodes a
transcription factor characterized by the presence of
three conserved domains [21], which is involved in the
regulation of organogenesis, myogenesis, brain and
limb development [20,22]. The first domain (DD1) at
the N-terminus (amino acids 66–162) and the second
domain (DD2) at the C-terminus (amino acids 452–
543) are highly conserved in all members of the DACH
protein family and appear to be involved in DNA bind-
ing and in the interaction with EYA proteins, respect-
ively [23,24]. A third domain DD3 is present in the
central portion of the protein (amino acids 314–412)
and is shared by all members of the DACH1 and
DACH2 subfamilies, but its detailed function remains
unknown. The variant c.1069A > T transition (p.S357C)
of DACH2 detected in the present study was located in
the DD3 domain and was predicted to be functionally
damaging by PolyPhen-2, suggesting a potential role in
two brothers’ phenotype. The combined mutations in
ABCD1 and DACH2 thus provide a plausible explanation
for the abnormal phenotype observed in both brothers.
However, further functional studies are needed to clarify
the effects of these variants.Conclusion
The distinct phenotype demonstrated by two brothers
might represent a new form of ALD or a new syndrome.
The combination of mutations in ABCD1 and DACH2
provides a plausible mechanism for this phenotype.
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